DOI: 10.26155/vet.zoo.bio.202010006
UDC 615.371: 616.921.5: 599.723.2: 615.065: 34.25.23: 59.084
Authors
N. N. Assanzhanova
Candidate of Medical Sciences, Head of the Laboratory for the Prevention
of Infectious Diseases, Scientific Research Institute for
Biological Safety Problems of the Science Committee
of the Ministry of Education and Science,
town. Gvardeisky, Republic of Kazakhstan
Sh. Zh. Ryskeldinova
Senior Researcher, Laboratory for the Prevention of Infectious
Diseases, Scientific Research Institute of
Biological Safety Problems of the Science Committee
of the Ministry of Education and Science,
town. Gvardeisky, Republic of Kazakhstan
D. A. Bugybayeva
Researcher, Laboratory for the Prevention of Infectious Diseases,
Scientific Research Institute for Biological Safety
Problems of the Science Committee of the
Ministry of Education and Science,
town. Gvardeisky, Republic of Kazakhstan
E. M. Kozhamkulov
Researcher, Laboratory for the Prevention of Infectious Diseases,
Scientific Research Institute for Biological Safety
Problems of the Science Committee of the
Ministry of Education and Science,
town. Gvardeisky, Republic of Kazakhstan
Zh. K. Kydyrbayev
Candidate of Veterinary Sciences, Professor, Chief Researcher,
Laboratory for the Prevention of Infectious Diseases,
Scientific Research Institute of Biological Safety
Problems of the Science Committee of the Ministry of Education and Science,
town. Gvardeisky, Republic of Kazakhstan
Abstract
The safety and immunogenicity of a pilot industrial series of a new live modified cold-adapted vaccine against equine influenza were studied. As a result of the work carried out, the vaccine was safe and immunogenic by the normative and technical documentation and can be recommended as a prophylactic for horses.
Keywords
equine influenza, live vaccine, cold-adapted strain, safety, immunogenicity.
